DUBLIN, Oct. 7, 2020 /PRNewswire/ — The “Medical Foods for Inborn Errors of Metabolism Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product; Age group; Disease; Forms; Packaging; Distribution Channel; and Geography” report has been added to ResearchAndMarkets.com’s offering.
The global medical foods for inborn errors of metabolism market are anticipated to reach US$ 5,768.79 million by 2027 from US$ 2,507.80 million in 2019. The market is projected to grow with a CAGR of 11.2% from 2020 to 2027.
Factors such as increasing incidences of inborn errors of metabolism and growing preference toward dietary food supplements are expected to boost the growth of the global medical foods for inborn errors of metabolism market. However, the market is likely to get impacted by the issues with medical foods for inborn errors of metabolism during the forecast period.
The rates for consumption of nutraceutical supplements and prescribed medical